logo

For the Inventor, By the Inventor

Asnieres, France

Jean-Claude Mazie

USPTO Granted Patents = 12 

Average Co-Inventor Count = 5.8

ph-index = 4

Forward Citations = 111(Granted Patents)


Location History:

  • Paris, FR (1990)
  • Asni{grave over (e)}res-sur-Seine, FR (2001)
  • Asnières-sur-Seine, FR (2003)
  • Asnierers-sur-Seine, FR (2005)
  • Asnieres, FR (2000 - 2010)
  • Asnieres sur Seine, FR (2003 - 2010)

Company Filing History:

goldMedal9 out of 869 
 
Institut Pasteur
 patents
silverMedal1 out of 21 
 
Centre Nationale De La Recherche Scientifique
 patents
bronzeMedal1 out of 1 
 
Institut Pasteur Paris
 patent
4. 1 out of 5,072 
 
Centre National De La Recherche Scientifique
 patents
5. 2 out of 832,718 
Other
 patents
where one patent can have more than one assignee

Years Active: 1990-2010

Loading Chart...
12 patents (USPTO):Explore Patents
1. 7704490 - Method for inducing selected useful activities of IL-2 in a patient with peptides from IL-2 (2010-04-27),
2. 7662368 - Method of inducing SHC phosphorylation of inducing the SHC/MAPK pathway by administering a peptide of IL-2 (2010-02-16),
3. 7101965 - Peptides of IL-2 (2006-09-05),
4. 6929791 - Peptides of IL-2 and derivatives thereof (2005-08-16),
5. 6825334 - Peptides of IL-2 and derivatives thereof and their use as therapeutic agents (2004-11-30),
6. 6770743 - Use of the KAL protein and treatment with the KAL protein in treatment of retinal, renal, neuronal and neural injury (2004-08-03),
7. 6596853 - DNA encoding peptides of IL-2 (2003-07-22),
8. 6559126 - Peptides blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis, polynucleotides encoding said peptides and methods of use thereof (2003-05-06),
9. 6548475 - Use of the KAL protein and treatment with the KAL protein in treatment of retinal, renal, neuronal and neural injury (2003-04-15),
10. 6168785 - Biological applications of new peptides of IL-2 and derivatives and use as therapeutic agents (2001-01-02),
11. 6121231 - Use of the KAL protein and treatment with the KAL protein in treatment (2000-09-19),
12. 4900661 - Method for immunological determination of amines, monoclonal antibodies (1990-02-13),

Title: Jean-Claude Mazie: Innovator in Therapeutic Peptides

Introduction

Jean-Claude Mazie is a prominent inventor based in Asnieres, France. He has made significant contributions to the field of therapeutic agents, particularly through his innovative work with interleukin-2 (IL-2) peptides. With a total of 12 patents to his name, Mazie's inventions have the potential to impact medical treatments significantly.

Latest Patents

Mazie's latest patents include a method for inducing selected useful activities of IL-2 in a patient using peptides derived from IL-2. This invention focuses on new peptides of IL-2 and their derivatives, highlighting their use as therapeutic agents. Another notable patent involves the method of inducing SHC phosphorylation, which activates the SHC/MAPK pathway by administering a peptide of IL-2. This invention also emphasizes the therapeutic potential of new IL-2 peptides and their derivatives.

Career Highlights

Throughout his career, Jean-Claude Mazie has worked with prestigious institutions, including the Institut Pasteur. His research and innovations have positioned him as a key figure in the development of peptide-based therapies.

Collaborations

Mazie has collaborated with notable professionals in his field, including Jacques Theze and Ralph Eckenberg. These collaborations have further enriched his research and contributed to the advancement of therapeutic peptide applications.

Conclusion

Jean-Claude Mazie's work in the field of therapeutic peptides showcases his innovative spirit and dedication to improving medical treatments. His contributions through patents and collaborations continue to pave the way for advancements in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…